Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,305,326
+$342,640 QoQ
Shares Held
21,083
-7.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#1,272
of 4,153 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Te Ahumairangi Investment Management Ltd holds $45,755,777 across 8 Drug Manufacturers - General names. ABBV ranks #6 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
31,084 | $7,894,403 | |
| 2 | AZN |
Astrazeneca PLC
|
34,479 | $6,537,907 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,511 | $6,490,663 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
48,936 | $6,182,574 | |
| 5 | PFE |
Pfizer Inc
|
237,946 | $5,729,739 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
21,083 | $5,305,326 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
79,705 | $4,592,602 | |
| 8 | LLY |
ELI LILLY & Co
|
2,520 | $3,022,563 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,305,326 | 21,083 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,962,686 | 22,818 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,653,884 | 20,368 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,244,381 | 22,650 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,423,324 | 23,830 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,324,492 | 20,640 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,099,894 | 23,072 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,356,803 | 22,062 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $3,799,511 | 22,152 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,103,077 | 22,532 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,410,424 | 22,007 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,168,568 | 21,257 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,199,129 | 31,167 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,038,754 | 25,342 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,940,817 | 18,197 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,603,271 | 19,397 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,956,294 | 19,302 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $3,574,201 | 22,048 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,449,765 | 77,177 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,004,663 | 83,477 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,442,498 | 83,829 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $9,071,974 | 83,829 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $8,553,677 | 79,829 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,501,718 | 74,229 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||